SS Innovations International, Inc. (SSII): Capital Expenditures

Annual figures by period end, from SEC filings.

$3.66M
Year ended 2025-12-31
+155.1%
3-year compound annual growth
2022-12-31: $220.3K2023-12-31: $453.3K2024-12-31: $661.5K2025-12-31: $3.66M$3.66M
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$3.66M+453.2%2026-03-10, From 2025-01-01
2024-12-31$661.5K+45.9%2026-03-10, From 2024-01-01
2023-12-31$453.3K+105.8%2025-04-15, From 2023-01-01
2022-12-31$220.3Kn/a2024-03-22, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
SS Innovations International, Inc. (SSII)2025-12-31$3.66M+453.2%
KORU Medical Systems, Inc. (KRMD)2025-12-31$932.5K-28.1%
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.94M+296.3%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$918.0K+166.1%
Interpace Biosciences, Inc. (IDXG)2025-12-31$356.0K-59.4%
Utah Medical Products Inc (UTMD)2025-12-31$371.0K+61.3%
Retractable Technologies Inc (RVP)2024-12-31$1.44M+68.8%
Shoulder Innovations, Inc. (SI)2025-12-31$7.41M+84.5%
Cytosorbents Corp (CTSO)2025-12-31$164.0K-42.3%

Compare SSII, KRMD, SNWV, TLSI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗